SMALL INTESTINE NEUROENDOCRINE TUMOUR

This adverse event was reported 55 times

These drugs are most commonly taken by patients reporting SMALL INTESTINE NEUROENDOCRINE TUMOUR:

# Drug Count
0 LUTETIUM LU 177 DOTATATE 18
1 OCTREOTIDE ACETATE 14
2 OCTREOTIDE 7
3 EVEROLIMUS 6
4 INTERFERON BETA-1B 4
5 BISOPROLOL FUMARATE 3
6 GRANISETRON 3
7 GRANISETRON HYDROCHLORIDE 3
8 PREDNISOLONE 3
9 PREDNISOLONE ORAL 3
See all common drugs associated with SMALL INTESTINE NEUROENDOCRINE TUMOUR

SMALL INTESTINE NEUROENDOCRINE TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STREPTOZOCIN 1 0.0043
1 LUTETIUM LU 177 DOTATATE 18 0.0031
2 OCTREOTIDE ACETATE 14 0.0005
3 ARSENIC TRIOXIDE 1 0.0004
4 CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE 1 0.0003
5 GRANISETRON HYDROCHLORIDE 3 0.0003
6 GRANISETRON 3 0.0003
7 INTERFERON BETA-1B 4 0.0002
8 UBROGEPANT 1 0.0002
9 ATOGEPANT 1 0.0001
See all drugs enriched for association with SMALL INTESTINE NEUROENDOCRINE TUMOUR